drug launches

Sarepta offers early look at closely watched gene therapy launch
Sarepta offers early look at closely watched gene therapy launch
BioPharma Dive
Sarepta Therapeutics
gene therapy
Duchenne Muscular Dystrophy
Elevidys
drug launches
Flag link:
Veeva Systems Reveals Results of Field Medical Engagement Impact Study
Veeva Systems Reveals Results of Field Medical Engagement Impact Study
Pharm Exec
Veeva
MSLs
drug launches
Flag link:
Why new Alzheimer’s drugs are in for a tepid launch
Why new Alzheimer’s drugs are in for a tepid launch
Medical Marketing and Media
Alzheimer's disease
drug launches
Biogen
Eisai
Leqembi
Flag link:
2023’s biggest launches: the story so far
2023’s biggest launches: the story so far
EP Vantage
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Flag link:
AstraZeneca CEO Pascal Soriot aims for 15 new drug launches by 2030
AstraZeneca CEO Pascal Soriot aims for 15 new drug launches by 2030
Endpoints
AstraZeneca
drug launches
Pascal Soriot
Pharma CEOs
Flag link:
Eisai gives first glimpse into Alzheimer’s drug launch
Eisai gives first glimpse into Alzheimer’s drug launch
BioPharma Dive
Eisai
Alzheimer's disease
drug launches
Leqembi
Flag link:
Lilly, Biogen and more gear up for blockbuster launches in 2023: report
Lilly, Biogen and more gear up for blockbuster launches in 2023: report
Fierce Pharma
Clarivate
drug launches
Eli Lilly
Biogen
GSK
Bristol Myers Squibb
Flag link:
JPM23: Karuna CEO says biotech can launch drugs, too, as deal rumors circulate
JPM23: Karuna CEO says biotech can launch drugs, too, as deal rumors circulate
Fierce Biotech
JPMHC 2023
Karuna Therapeutics
drug launches
schizophrenia
KarXT
Flag link:
Karuna parts ways with executive as it gears up for schizophrenia drug's high-profile launch
Karuna parts ways with executive as it gears up for schizophrenia drug's high-profile launch
Fierce Biotech
Karuna Therapeutics
schizophrenia
KarXT
drug launches
Flag link:
Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report
Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report
Fierce Pharma
Pfizer
Pharma CEOs
Albert Bourla
drug launches
COVID-19
vaccines
Flag link:
Novartis wins on quantity, but Eli Lilly takes the cake on value of new launches: report
Novartis wins on quantity, but Eli Lilly takes the cake on value of new launches: report
Fierce Pharma
Novartis
Eli Lilly
drug launches
Mounjaro
Flag link:
The Inflation Reduction Act’s Potential Impact on Research, Launch Strategy
The Inflation Reduction Act’s Potential Impact on Research, Launch Strategy
BioSpace
Inflation Reduction Act
Medicare
R&D
drug launches
Flag link:
Pharma’s post-pandemic launch performance problem: what’s the prognosis?
Pharma’s post-pandemic launch performance problem: what’s the prognosis?
Pharmaforum
pandemic
COVID-19
IQVIA
drug launches
innovation
Flag link:
Idorsia's recently approved insomnia drug Quviviq hits the shelves
Idorsia's recently approved insomnia drug Quviviq hits the shelves
Bizjournals
Idorsia
drug launches
insomnia
Quviviq
Flag link:
With Bayer's new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long?
With Bayer's new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long?
Fierce Pharma
Bayer
Eylea
Xarelto
drug launches
Flag link:
Organon CEO pins high hopes on upcoming Humira biosimilar launch
Organon CEO pins high hopes on upcoming Humira biosimilar launch
Fierce Pharma
Organon
biosimilar
Humira
drug launches
AbbVie
Flag link:
The biggest launches of 2022: a reboot
The biggest launches of 2022: a reboot
EP Vantage
drug launches
Eli Lilly
tirzepatide
Alnylam
vutrisiran
Roche
Vabysmo
JNJ
Carvykti
Mirati Therapeutics
adagrasib
Bristol Myers Squibb
mavacamten
deucravacitinib
Flag link:
Roche pharma CEO Anderson talks up Vabysmo’s 'very strong launch' plans as Eylea battle looms
Roche pharma CEO Anderson talks up Vabysmo’s 'very strong launch' plans as Eylea battle looms
Fierce Pharma
Roche
Vabysmo
drug launches
Bill Anderson
Eylea
Flag link:
Novartis says Leqvio launch will feature a 'modest initial ramp,' but blockbuster potential awaits
Novartis says Leqvio launch will feature a 'modest initial ramp,' but blockbuster potential awaits
Fierce Pharma
Novartis
Leqvio
drug launches
Cardiovascular
Flag link:
JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn't plan to stop there, exec says
JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn't plan to stop there, exec says
Fierce Pharma
JPMHC 2022
Novartis
Leqvio
drug launches
Regeneron
Amgen
Sanofi
Flag link:

Pages